APA (7th ed.) Citation

MR, T., N, M., E, B., S, S., J, I., A, H., . . . J, B. (2023). Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy. Diabetologia, 66(12), 2307. https://doi.org/10.1007/s00125-023-06008-0

Chicago Style (17th ed.) Citation

MR, Taskinen, et al. "Contribution of Intestinal Triglyceride-rich Lipoproteins to Residual Atherosclerotic Cardiovascular Disease Risk in Individuals with Type 2 Diabetes on Statin Therapy." Diabetologia 66, no. 12 (2023): 2307. https://doi.org/10.1007/s00125-023-06008-0.

MLA (9th ed.) Citation

MR, Taskinen, et al. "Contribution of Intestinal Triglyceride-rich Lipoproteins to Residual Atherosclerotic Cardiovascular Disease Risk in Individuals with Type 2 Diabetes on Statin Therapy." Diabetologia, vol. 66, no. 12, 2023, p. 2307, https://doi.org/10.1007/s00125-023-06008-0.